The ArteraAI Prostate Test is transforming the risk stratification landscape for treating localized prostate cancer. Watch this webinar to learn about how this test is being utilized by urologists and radiation oncologists across the country to optimize cancer care.
Dr. Peter Fried (Radiation Oncologist, Urology Group) and Dr. Nitin Yerram (Urologist, Hackensack University) joins Dr. Timothy Showalter (Chief Medical Officer, Artera) in reviewing the Past, Present, and Future of the ArteraAI Prostate Test.
Watch the video for a lively discussion on:
- How the test was developed and validated
- 6 Real-world patient cases, including how the test impacted treatment decisions
- Ongoing research into the biological underpinnings of the MMAI model
Fill out the form below to view the recording…
The ArteraAI Prostate Test is transforming the risk stratification landscape for treating localized prostate cancer. Watch this webinar to learn about how this test is being utilized by urologists and radiation oncologists across the country to optimize cancer care.
Dr. Peter Fried (Radiation Oncologist, Urology Group) and Dr. Nitin Yerram (Urologist, Hackensack University) joins Dr. Timothy Showalter (Chief Medical Officer, Artera) in reviewing the Past, Present, and Future of the ArteraAI Prostate Test.
Watch below for a lively discussion on:
- How the test was developed and validated
- 6 Real-world patient cases, including how the test impacted treatment decisions
- Ongoing research into the biological underpinnings of the MMAI model
